PATENT PURCHASE AGREEMENTPatent Purchase Agreement • December 19th, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec • Texas
This PATENT PURCHASE AGREEMENT (“Agreement”) is entered into and made effective as of this 13th day of December 2024 (“Effective Date”) by and between Mangoceuticals, Inc., a Texas corporation with a place of business at 15110 Dallas Parkway, Suite 600, Dallas, TX 75248 (“Purchaser”), and Greenfield Investments, Ltd, a Turks and Caicos limited company, with a place of business at Suites A201& A202 (Upstairs), Regent Village East, Grace Bay, Providenciales, Turks and Caicos Islands (“Seller”) (each of Seller and Purchaser is defined herein as a “Party”, and collectively referred to as the “Parties”).
NOTE PURCHASE AGREEMENTNote Purchase Agreement • December 19th, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec • Texas
This Note Purchase Agreement (this “Agreement”) is entered into effective as of December 13, 2024 (the “Effective Date”), by and between Mill End Capital Ltd., a British Virgin Islands limited company (“Purchaser”), and Cohen Enterprises, Inc., a Texas corporation (“Note Holder”). Purchaser and Note Holder (each, a “Party” and, together, the “Parties”) agree as follows with respect to that certain outstanding Promissory Note dated October 18, 2024 issued by Mangoceuticals, Inc., a Texas corporation (the “Company”) to Note Holder in the original principal amount of $150,000 (the “Note”, a copy of which is attached hereto as Exhibit A):
PARENT SUBSIDIARY CONTRIBUTION AGREEMENTParent Subsidiary Contribution Agreement • December 19th, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec • Texas
This Parent Subsidiary Contribution Agreement (this “Contribution Agreement”) dated December 13th , 2024 and effective as of the Effective Time (as defined in Section 11), is entered into by and between Mangoceuticals, Inc., a Texas corporation (“Parent”), and Mango & Peaches Corp., a Texas corporation and wholly-owned subsidiary of Parent (“Subsidiary”).
MANGOCEUTICALS, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT JACOB COHEN CHIEF EXECUTIVE OFFICERExecutive Employment Agreement • December 19th, 2024 • Mangoceuticals, Inc. • Services-misc health & allied services, nec • Texas
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into this 13th day of December 2024, to be effective as of the Effective Date as defined below between Mangoceuticals, Inc., a Texas corporation (the “Company”), and Jacob Cohen (“Executive”) (each of the Company and Executive are referred to herein as a “Party”, and collectively referred to herein as the “Parties”).
